Growth/Risk Asset Rally Dichotomy To Continue

Happy New Year!  2020 ended with record highs for US stock markets, capping off a solid year for risk assets amid massive and ongoing central bank liquidity injections.  In contrast the dollar index (DXY) ended the year languishing around its lowest levels since April 2018.  The dichotomy between the sharp deterioration in global growth and risk asset performance has widened dramatically.  Given the acceleration in COVID-19 cases over recent weeks and consequent lockdowns, especially in the US and Europe, this divergence is likely to be sustained and even widen further over the next few months, at least until various vaccines finally manage to stem the damage.

Two of the biggest stumbling blocks for markets over recent weeks/months have been US fiscal stimulus and Brexit.  Both have now passed with last minute deals, setting the scene for a clearer path in the weeks ahead though political obstacles have not disappeared by any means, with the Georgia Senate run-off elections scheduled for Tuesday.  The outcome will be crucial for control of the US Senate with Democrats needing wins in both races to take over. However, the races are too close to call according to polls. Separately the US Congress will meet on Wednesday to declare the winner of the Presidential election. 

On the data and events front the week begins with an OPEC+ meeting tomorrow, with officials deliberating on whether to expand output by up to 500k barrels.  There are also a series of December Markit manufacturing purchasing managers indices (PMI) tomorrow including in various countries in Asia as well as the release of the Caixin manufacturing PMI in China.  US data will take centre stage with the release of the ISM manufacturing survey (Tuesday), Federal Reserve FOMC minutes (Wednesday) and non-farm payrolls (Friday).  Overall, markets are likely to begin the year much as the same way they left 2020, with risk appetite remaining firm. 

One interesting observation as we kick off 2021 is that so many investor and analysts’ views are aligned in the same direction (long Emerging markets, short USD, long value stocks, etc), and positioning is already looking stretched in various asset classes as a result.  While I would caution against catching a falling knife there is a clearly a risk of jumping on the same bandwagon as everybody else in a market that is increasingly positioned in one direction.  Overall, while the risk rally is likely to continue to have legs in the months ahead, investors should be on their toes in the weeks ahead given risks of a positioning squeeze in various asset classes.

Going “The Extra Mile”

Risk assets ended last week on a soft note as Brexit uncertainties intensified amid a lack of progress towards a transition deal.  However, news overnight was a little more promising, as PM Johnson and EC President von der Leyen agreed to “go the extra mile” to try to agree up on a deal.  “Incremental” progress has reportedly been made and talks could now continue up to Christmas.  Sterling (GBP) rallied on the news and further gains are likely on any deal.  However, gains may prove short lived, with markets likely to focus on the economic difficulties ahead of the UK economy.  A no deal outcome is likely to result in a much sharper decline in GBP, however.

Progress towards fresh US fiscal stimulus progress faltered leaving US equity markets on shaky ground.  As it is, US stocks have struggled to extend gains over December after a stellar month in November and in recent days momentum has faded further.  Last week 9 out of 11 S&P sectors fell, suggesting broad based pressure.  Whether it is just a case of exhaustion/profit taking after solid year-to-date gains – for example, Nasdaq is up almost 38% and S&P up 13.4%, ytd – or something more alarming is debatable.  The massive amount of liquidity sloshing around and likely more dovishness from the Fed this week, would suggest the former.  

At the same time the US dollar (DXY) and broader BDXY are down almost 6% and 5% respectively, this year and most forecasts including our own look for more USD weakness next year.  Some of this is likely priced in as reflected in 27 straight weeks of negative aggregate USD (vs major currencies) positioning as a % of open interest (CFTC). The USD looks a little firmer this month, but gains are tentative and like equities this could simply reflect profit taking.  For example, in Asian currencies that have performed well this year such as the offshore Chinese yuan (CNH) and Korean won (KRW), fell most last week, partly due to increased central bank resistance. 

This week is a heavy one for events and data.  The main event on the calendar is the Federal Reserve FOMC meeting (Wed).  The Fed could include new forward guidance stating that quantitative easing (QE) will continue until there is clear-cut progress toward the employment and inflation goals.  The Fed may also lengthen the average maturity of asset purchases. Central bank decisions in Hungary (Tue), UK, Norway, Indonesia, Taiwan, Philippines (all on Thu), Russia, Japan and Mexico (all on Fri) will also be in focus though no changes in policy are likely from any of them.   On the data front China activity data (Tue), Canada CPI (Wed), US retail sales (Wed), and Australian employment (Thu) will be main highlights.

A Stellar Month

November has turned into a stellar month for risk assets, with major equity benchmarks globally, especially those that are dominated by value/cyclical stocks, performing particularly well.  Investors have been willing to bypass the escalation in Covid infections in the US and Europe and instead focus on the upside potential presented by new vaccines and a new US administration, with a line up including former Federal Reserve Chair Yellen, that is likely to be more trade friendly.  Ultra-low rates and likely even more moves in a dovish direction from the Fed as well as plenty of central bank liquidity continue to support risk assets.  While challenges lie ahead (weakening growth, Covid intensification, lack of fiscal stimulus, withdrawal of Fed emergency measures) as well as technical barriers to further short-term gains, the medium-term outlook has become rosier.   

China’s economy has led the recovery and provided plenty of support to Asian markets, commodity prices and currencies. This week’s data and events kicks off with China’s official manufacturing purchasing managers index (PMI) (consensus. 51.5) (Mon) which is likely to remain in expansion, providing further support for China linked economies and assets.  However, the impact on oil will also depend on the OPEC+ meeting (Mon and Tue). Despite the sharp 30% rally in oil prices over the month further output increases are likely to be delayed as producers look to solidify gains. That said, a lot of good news appears to have been priced into the oil market already.  In contrast, the US dollar has been a casualty of the improvement in risk appetite and has shown little sign over reversing its losses. Subdued over recent days by year end selling, the USD may show more signs of life this week. 

The other key event this week is the Nov US jobs report (Fri) where a slowing pace of job gains is likely (consensus 500,000, last 638,000), with new COVID restrictions taking a toll on employment. US Nov ISM surveys are also likely to soften (Tue & Thu), albeit remaining firmly in expansion.  In Canada, the federal fiscal update (Mon), Q3 GDP (Tue) and jobs data (Fri) will be in focus.  Australia also releases its Q3 GDP report (Wed) while In Europe the flash Nov HICP inflation reading will garner attention but most attention will be on ongoing Brexit discussions, which seem to be stuck on remaining issues such as fishing rights. Central bank policy decisions in Australia (Tue), Poland (Wed) and India (Fri) are likely to prove uneventful, with no policy changes likely. 

Asia In Demand

Equity markets managed to shake off Covid concerns at the end of last week despite virus cases in the US reaching a record high and Europe battling a full-blown second wave; S&P 500 and Russell 2000 hit record highs.  Asian equities started the week building on this positive momentum.  Helping markets was the news that advisors to President-elect Joe Biden have said they oppose a nationwide US lockdown despite the sharp rise in virus cases.  This will help allay fears that the US economy will weaken sharply over the next few months amid severe lockdowns and before a vaccine can be distributed.

Vaccine enthusiasm will likely play against Covid escalation in the days and weeks ahead. In the near-term slim chances of a sizeable US fiscal stimulus taken together with a more rapid increase in global Covid infections highlight clear risks to risk assets, and this may be enough to put roadblocks in place at a time when various equity indices are reaching key technical levels.  Conversely, it is too early to write the US dollar off in the short term even if the medium-term trend is likely to be downwards. 

Asia remains favoured within emerging markets, as the virus has come under control across most of the region.  News of the signing of the Regional Comprehensive Economic Partnership (RCEP) trade deal by 15 countries in the region after 8 years of negotiations, but without the US and India, provides another boost to regional economic and market prospects.  The deal is less extensive than the Trans-Pacific Partnership (TPP) as it removes around 90% of tariffs rather than 100% under TPP.  Nonetheless, it is estimated that the deal could boost the global economy by close to $200bn by 2030.  Although the deal still has to be ratified by a number of countries it is a step closer to a unified trade block like the EU.   

Additionally, Chinese data today ought to be supportive for regional assets even amid the threat of further sanctions by President Trump’s administration in the weeks ahead. China’s October activity data including industrial production fixed assets investment, property investment and the jobless rate were on balance positive, showing that China’s economic recovery is gathering steam.  The data will likely provide further support to China’s markets including China’s currency, though it effectively seals the case for no further easing by China’s central bank, PBoC, while giving the rest of Asia more fuel to rally. 

Over the rest of the week emerging markets central banks will garner most attention, with a plethora of policy rate decisions on tap.  Hungary (Tue), Thailand (Wed), Philippines (Thu), South Africa (Thu), and China (Fri) are set to keep policy rates on hold while Indonesia (Thu) is likely to cut by 25bps and Turkey is expected to hike its policy rate by 475bp hike (Thu).   Turkey in particular will be a focus in this respect given the replacement of central bank governor and the more than 10% rally in the Turkish lira last week.

Game Changer

Pfizer and BioNTech’s game changing announcement that its vaccine had been found to be more than 90% effective in a late stage trial added more fuel on a stock market rally that was already underway following President-elect Biden’s election win and likely split Congress.  It was the time for beaten up value/travel/oil stocks to shine while conversely stay at home stocks have come under pressure.  However, that story appeared to reverse overnight, with tech stocks making a comeback, suggesting that it’s not going to be a one way bet for value stocks. 

One obstacle is the rampant increase in virus cases in the US and Europe and risks of more lockdowns. Though the vaccine news is clearly positive its worth highlighting that it could take some time for any vaccine to be rolled out in sufficient numbers to allow for an opening up of economies anytime soon.  In the meantime, we still have to contend with a big wave of virus infections in Europe and US, which implies more economic pain to come.  All of this could put a renewed dampener on risk sentiment and limit the rally in stocks in the near term.  

Technical indicators (Relative Strength Index) suggest resistance in the short term; for example, the US Russell 2000 index (a broad small cap index) is verging on hitting Fibonacci retracement levels around 1746, while its also above its upper Bollinger band.  Not helping tech stocks is the regulatory stance, with Amazon hit by an antitrust charge from regulators in the EU.  The USD’s weakness also looks overdone in the short term. In particular, technical indicators show that Asian currencies and dollar bloc currencies (CAD, AUD, NZD) look stretched. The USD is likely to make further gains in the short term even as its medium term outlook remains more negative.

Meanwhile Republicans are increasingly standing with President Trump in not accepting the outcome of the election, fuelling concerns about the transition process, even as President-elect Biden’s lead in various states has grown. Many are doing so with an eye on 2024 elections. Georgia is auditing the presidential results in its state by hand, but even so, it seems extremely unlikely that Trump can reverse Biden’s 14k lead in the state and even if that does occur it wouldn’t change the outcome.